Premium
How far should we treat metastatic liver cancer? Report of three long‐term survivors
Author(s) -
Tsuzuki Toshiharu,
Ueda Masakazu,
Kobayashi Koichi,
Suzuki Takashi,
Tazaki Hiroshi,
Tachibana Masaaki,
Iri Hisami
Publication year - 1996
Publication title -
journal of hepato‐biliary‐pancreatic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.63
H-Index - 60
eISSN - 1868-6982
pISSN - 0944-1166
DOI - 10.1007/bf01212780
Subject(s) - medicine , surgery , metastasis , major duodenal papilla , cancer , nephrectomy , bile duct cancer , mediastinum , duodenum , general surgery , bile duct , kidney
The major issue in treating metastatic liver cancer is: how far should we perform resection? We believe that only reports of long‐term survival afford an answer to this problem. We report three such patients. The first patient underwent pancreatoduodenectomy for cancer of the papilla of the duodenum and resection of metastatic liver cancer. She is alive without recurrence 15 years and 1 month after the initial surgery. The second patient received low anterior resection for rectal cancer, extended right lobectomy for liver metastasis, and pancreatoduodenectomy for metastasis at the common bile duct. She survived 6 years and 9 months after the initial surgery. The third patient underwent right nephrectomy for Wilms' tumor (adult type), extended right lobectomy for liver metastasis, and repeat resection of recurrences at the mediastinum and in the thoracic and abdominal walls. She is alive 21 years and 2 months after the initial surgery. These experiences have prompted us to carry out resection when surgery is deemed feasible.